EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use

Carlos Roncero, Lorenzo Armenteros, Carmen Bellido-Cambrón, Amparo Bonilla-Guijarro, Emilio Gómez-Cibeira

Frontiers in Pharmacology · 20.05.2025 · 16

DOI: 10.3389/fphar.2025.1547488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.05.2025. Verfasst von Carlos Roncero und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Faculty, European University Miguel de Cervantes, Valladolid, Spain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzodiazepines are among the most widely prescribed treatments for insomnia, and can have positive effects on sleep when used for a maximum of 4 weeks. However, benzodiazepines disrupt sleep architecture, and their long-term use leads to negative outcomes, including impairments in memory and attention, increased risk of falls (particularly in the elderly) and car accidents, dependence, and addiction. In addition, stopping benzodiazepines after long-term use can result in severe withdrawal symptoms. Spain is one of the countries with the most widespread benzodiazepine use. A multidisciplinary approach is crucial for the treatment of insomnia and for preventing benzodiazepine overuse/misuse. The present study provides an updated overview of the epidemiology and use of these drugs in vulnerable populations (adolescents, older adults and people with mental disorders). We also describe deprescribing strategies used in clinical practice and present two case studies to exemplify the complexities of benzodiazepine withdrawal observed in our practice. Finally, proposals are provided for the rational use of benzodiazepines in Spain, targeted to the general population, healthcare professionals, and regulatory authorities, in order to improve the clinical management of insomnia.

Schlagwörter

Stichwörter der Autor:innen

abusebenzodiazepinesinsomniamisuseoveruseresponsible usesleep

Autor:innen und Institutionen

  • Health Science Faculty, European University Miguel de Cervantes, Valladolid, Spain.
  • Pychiatric Unit, School of Medicine, Instituto de Investigación Biomédica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
  • Islas Canarias Health Center of Lugo, Lugo, Spain.
  • Spanish Society of General and Family Physicians (SEMG), Madrid, Spain.
  • Occupational Risk Prevention Department, Peripheral Unit No. 1, General University Hospital of Castellón, Castellón, Spain.
  • Spanish Association of Occupational Medicine, Madrid, Spain.

Zitieren

APA

Roncero, C., Armenteros, L., Bellido-Cambrón, C., Bonilla-Guijarro, A., & Gómez-Cibeira, E. (2025). Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1547488

Vancouver

Roncero C, Armenteros L, Bellido-Cambrón C, Bonilla-Guijarro A, Gómez-Cibeira E. Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1547488

BibTeX
@article{Roncero2025,
  author = {Roncero, Carlos and Armenteros, Lorenzo and Bellido-Cambrón, Carmen and Bonilla-Guijarro, Amparo and Gómez-Cibeira, Emilio},
  title = {Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1547488}
}
Kostenlos starten →